Skip to main content

Barclays Sticks to Their Buy Rating for Bayer (0P6S)

Tipranks - Tipranks - Tue Mar 10, 3:14AM CDT

Barclays analyst Charles Pitman CFA maintained a Buy rating on Bayer today and set a price target of €48.00.

Claim 70% Off TipRanks Premium

Pitman CFA covers the Healthcare sector, focusing on stocks such as UCB SA, Merck KGaA, and Recordati Industria Chimica e Farmaceutica SPA. According to TipRanks, Pitman CFA has an average return of 13.0% and a 61.22% success rate on recommended stocks.

In addition to Barclays, Bayer also received a Buy from Goldman Sachs’s James Quigley in a report issued on March 4. However, on March 6, TipRanks – OpenAI reiterated a Hold rating on Bayer (LSE: 0P6S).

See today’s best-performing stocks on TipRanks >>

0P6S market cap is currently €35.75B and has a P/E ratio of -10.04.

Based on the recent corporate insider activity of 9 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of 0P6S in relation to earlier this year.

Read More on GB:0P6S:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).